Novel lead structures and activation mechanisms for CO-releasing molecules (CORMs)

British Journal of Pharmacology

Volumn 172, Issue 6, 2015, Pages 1638-1650

  Schatzschneider, U ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

carbon monoxide; CO releasing molecules; CORMs; ET CORMs; haem oxygenase; PhotoCORMs

Indexed keywords

BORON DIPYRROMETHENE DIFLUORIDE; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE; CARBOXYMYOGLOBIN; CHEMICAL COMPOUND; COORDINATION COMPOUND; GUANYLATE CYCLASE; GUANYLATE CYCLASE ACTIVATOR; HEME OXYGENASE; NANOSPHERE; TRANSITION ELEMENT; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN; HEME; METAL; NANOMATERIAL; PRODRUG;

ANALYTIC METHOD; BINDING AFFINITY; BIOACCUMULATION; BIOLOGICAL ACTIVITY; CHEMICAL REACTION KINETICS; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; FLUORESCENCE ANALYSIS; GAS ANALYSIS; LIGAND BINDING; MASS SPECTROMETRY; METAL BINDING; MOLECULAR PROBE; MOLECULAR STABILITY; NANOANALYSIS; NANOCHEMISTRY; NANOPROBE; PHOTOACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SPECTROPHOTOMETRY; STOICHIOMETRY; STRUCTURE ANALYSIS; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARBON MONOXIDE; COORDINATION COMPLEXES; HEME; HEME OXYGENASE (DECYCLIZING); HUMANS; METALS; NANOSTRUCTURES; PRODRUGS; SIGNAL TRANSDUCTION;

EID: 84923646224     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12688     Document Type: Review

References (98)

1. Abraham NG, Kappas A, (2008). Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127.
2. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. (2011). Photodynamic therapy of cancer: an update. CA Cancer J Clin 61: 250-281.
3. Alessio E, Mestroni G, Bergamo A, Sava G, (2004). Ruthenium antimetastatic agents. Curr Top Med Chem 4: 1525-1535.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Ligand-gated ion channels. Br J Pharmacol 170: 1582-1606.
5. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Ion channels. Br J Pharmacol 170: 1607-1651.
6. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
7. Antony LAP, Slanina T, Sebej P, Solomek T, Klan P, (2013). Fluorescein analogue xanthene-9-carboxylic acid: a transition-metal-free CO releasing molecule activated by green light. Org Lett 15: 4552-4555.
8. Atkin AJ, Lynam JM, Moulton BE, Sawle P, Motterlini R, Boyle NM, et al. (2011). Modification of the deoxy-myoglobin/carbonmonoxy-myoglobin UV-vis assay for reliable determination of CO-release rates from organometallic carbonyl complexes. Dalton Trans 40: 5755-5761.
9. Bernardi C, Chiesa LM, Soncin S, Passero E, Biondi PA, (2008). Determination of carbon monoxide in tuna by gas chromatography with micro-thermal conductivity detector. J Chromat Sci. 46: 392-394.
10. 3 complexes with variable chain lengths as enzyme-triggered carbon monoxide-releasing molecules. Organometallics 32: 3587-3594.
11. Bratsos I, Jedner S, Gianferrara T, Alessio E, (2007). Ruthenium anticancer compounds: challenges and expectations. Chimia (Aarau) 61: 692-697.
12. Chen H, Moreau Y, Derat E, Shaik S, (2008). Quantum mechanical/molecular mechanical study of mechanisms of heme degradation by the enzyme heme oxygenase: the strategic function of the water cluster. J Am Chem Soc 130: 1953-1965.
13. Cuevasanta E, Denicola A, Alvarez B, Möller MN, (2011). Solubility and permeability of hydrogen sulfide in lipid membranes. PLoS ONE 7: e34562.
14. Derbyshire ER, Marletta MA, (2012). Structure and regulation of soluble guanylate cyclase. Ann Rev Biochem. 81: 533-559.
15. Dördelmann G, Pfeiffer H, Birkner A, Schatzschneider U, (2011). Silicium dioxide nanoparticles as carriers for photoactivatable CO releasing molecules (PhotoCORMs). Inorg Chem 50: 4362-4367.
16. +. Chem Commun 48: 11528-11530.
17. Elschenbroich C, (2006) Organometallics, 3rd edn. Wiley-VCH: Weinheim.
18. Foresti R, Motterlini R, (2010). Interaction of carbon monoxide with transition metals: evolutionary insights into drug target discovery. Curr Drug Targets 11: 1595-1604.
19. 2 activation. J Biol Chem 278: 34654-34659.
20. Fukuto JM, Carrington SJ, Tantillo DJ, Harrison JG, Ignarro LJ, Freeman BA, et al. (2012). Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species. Chem Res Toxicol 25: 769-793.
21. Goldbaum LR, Ramirez RG, Absalon KB, (1975). What is the mechanism of carbon monoxide toxicity? Aviat Space Environ Med 46: 1289-1291.
22. Gonzalez MA, Fry NL, Burt R, Davda R, Hobbs A, Mascharak PK, (2011). Designed Iron carbonyls as carbon monoxide (CO) releasing molecules: rapid CO release and delivery to myoglobin in aqueous buffer, and vasorelaxation of mouse aorta. Inorg Chem 50: 3127-3134.
23. Gonzalez MA, Carrington SJ, Fry NL, Martinez JL, Mascharak PK, (2012a). Syntheses, structures, and properties of new manganese carbonyls as photoactive CO-releasing molecules: design strategies that lead to CO photolability in the visible region. Inorg Chem 51: 11930-11940.
24. Gonzalez MA, Yim MA, Cheng S, Moyes A, Hobbs AJ, Mascharak PK, (2012b). Manganese carbonyls bearing tripodal polypyridine ligands as photoactive carbon monoxide-releasing molecules. Inorg Chem 51: 601-608.
25. Govender P, Pai S, Schatzschneider U, Smith G, (2013). Next generation PhotoCORMs: polynuclear tricarbonylmanganese(I)-functionalized polypyridyl metallodendrimers. Inorg Chem 52: 5470-5478.
26. Gupta N, Ragsdale SW, (2011). Thiol-disulfide redox dependence of heme binding and heme ligand switching in nuclear hormone receptor Rev-erbβ. J Biol Chem 286: 4392-4403.
27. Hasegawa U, van der Vlies AJ, Simeoni E, Wandrey C, Hubbell JA, (2010). Carbon monoxide-releasing micelles for immunotherapy. J Am Chem Soc 132: 18273-18280.
28. 2+ sensor confers carbon monoxide sensitivity to Slo1 BK channels. Proc Natl Acad Sci 105: 4039-4043.
29. Hou S, Heinemann SH, Hoshi T, (2009). Modulation of BKCa channel gating by endogenous signaling molecules. Physiology 24: 26-35.
30. Ibrahim M, Derbyshire ER, Marletta MA, Spiro TG, (2010). Probing soluble guanylate cyclase activation by CO and YC-1 using resonance Raman spectroscopy. Biochemistry 49: 3815-3823.
31. Ignarro LJ, (1999). Nitric oxide: a unique endogenous signaling molecule in vascular biology. Angew Chem Int Ed 38: 1882-1892.
32. 3Cl(glycinate)], a CO-releasing molecule with an extensive aqueous solution chemistry. Dalton Trans: 1500-1508.
33. 2S gas biology. Antioxid Redox Signal 13: 157-192.
34. Kajimura M, Nakanishi T, Takenouchi T, Morikawa T, Hishiki T, Yukutake Y, et al. (2012). Gas biology: tiny molecules controlling metabolic systems. Resp Physiol Neurobiol 184: 139-148.
35. Kim HP, Ryter SW, Choi AMK, (2006). CO as a cellular signaling molecule. Ann Rev Pharmacol Toxicol 46: 411-449.
36. Kunz PC, Meyer H, Barthel J, Sollazzo S, Schmidt AM, Janiak C, (2013). Metal carbonyls supported on iron oxide nanoparticles to trigger the CO-gasotransmitter release by magnetic heating. Chem Commun 49: 4896-4898.
37. Lai W, Chen H, Matsui T, Omori K, Unno M, Ikeda-Saito M, et al. (2010). Enzymatic ring-opening mechanism of verdoheme by the heme oxygenase: a combined X-ray crystallography and QM/MM study. J Am Chem Soc 132: 12960-12970.
38. Lane N, (2003). New light on medicine. Sci Am January: 38-45.
39. Levina A, Mitra A, Lay PA, (2009). Recent developments in ruthenium anticancer drugs. Metallomics 1: 458-470.
40. Li C, Hossieny P, Wu BJ, Qawasmeh A, Beck K, Stocker R, (2007). Pharmacological induction of heme oxygenase-1. Antioxid Redox Signal 9: 2227-2239.
41. Li L, Rose P, Moore PK, (2011). Hydrogen sulfide and cell signaling. Ann Rev Pharmacol Toxicol 51: 169-187.
42. Ma M, Noei H, Mienert B, Niesel J, Bill E, Muhler M, et al. (2013). Iron metal-organic frameworks MIL-88B and NH2-MIL-88B for the loading and delivery of the gasotransmitter carbon monoxide. Chem Eur J 19: 6785-6790.
43. Mann BE, (2010) Carbon monoxide: an essential signalling molecule. In:, Metzler-Nolte N, Jaouen G, (eds). Top. Organomet. Chem.; Vol. 32. Springer: Berlin, pp. 247-285.
44. Marques AR, Kromer L, Gallo DJ, Penacho N, Rodrigues SS, Seixas JD, et al. (2012). Generation of carbon monoxide releasing molecules (CO-RMs) as drug candidates for the treatment of acute liver injury: targeting of CO-RMs to the liver. Organometallics 31: 5810-5822.
45. Matson JB, Webber MJ, Tamboli VK, Weber B, Stupp SI, (2012). A peptide-based material for therapeutic carbon monoxide delivery. Soft Matter 8: 6689-6692.
46. Matsui T, Unno M, Ikeda-Saito M, (2010). Heme oxygenase reveals its strategy for catalyzing three successive oxygenation reactions. Acc Chem Res 43: 240-247.
47. McKenna CE, Gutheil WG, Song W, (1991). A method for preparing analytically pure sodium dithionite. Dithionite quality and observed nitrogenase-specific activities. Biochim Biophys Acta 1075: 109-117.
48. McLean S, Mann BE, Poole RK, (2012). Sulfite species enhance carbon monoxide release from CO-releasing molecules: implications for the doxymyoglobin assay of activity. Anal Biochem 427: 36-40.
49. Melchart M, Sadler PJ, (2006). Ruthenium arene anticancer complexes. In:, Jaouen G, (ed.). Bioorganometallic. Wiley-VCH.: Weinheim, pp. 39-64.
50. Michel BW, Lippert AR, Chang CJ, (2012). A reaction-based fluorescent probe for selective imaging of carbon monoxide in living cells using a palladium-mediated carbonylation. J Am Chem Soc 134: 15668-15671.
51. Morse D, Choi AMK, (2002). Heme oxygenase-1: the 'emerging molecule' has arrived. Am J Respir Cell Mol Biol 27: 8-16.
52. Motterlini R, Otterbein LE, (2010). The therapeutic potential of carbon monoxide. Nature Rev Drug Discovery 9: 728-743.
53. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ, (2002). Carbon-monoxide-releasing molecules-characterization of biochemical and vascular activity. Circ Res 90: e17-e24.
54. Motterlini R, Sawle P, Bains S, Hammad J, Alberto R, Foresti R, et al. (2004). CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 18: 284-286.
55. Mustafa AK, Gadalla MM, Snyder SH, (2009). Signaling by gasotransmitters. Sci Signal. 2: 1-8, re2.
56. Niesel J, Pinto A, Peindy N, Dongo HW, Merz K, Ott I, et al. (2008). Photoinduced CO release, cellular uptake, and cytotoxicity of a tris(pyrazolyl)methane manganese tricarbonyl complex. Chem Commun: 1798-1800.
57. Peng P, Wang C, Shi Z, Johns VK, Ma Y, Oyer J, et al. (2013). Visible-light activatable organic CO-releasing molecules (PhotoCORMs) that simultaneously generate fluorophores. Org Biomol Chem 11: 6671-6674.
58. +-based CO releasing molecules (tpm = tris(pyrazolyl)methane). Dalton Trans: 4292-4298.
59. 4 PhotoCORM to a bacteria-targeting phage peptide. J Organomet Chem 734: 17-24.
60. Piantadosi CA, (2008). Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Rad Biol Med 45: 562-569.
61. Pierri AE, Pallaoro A, Wu G, Ford PC, (2012). A luminescent and biocompatible PhotoCORM. J Am Chem Soc 134: 18197-18200.
62. Pitchumony TS, Spingler B, Motterlini R, Alberto R, (2008). Derivatives of sodium boranocarbonate as novel CO-releasing molecules (CO-RMs). Chimia (Aarau) 62: 277-279.
63. - derivatives. Org Biomol Chem 8: 4849-4954.
64. Podust LM, Ioanoviciu A, Ortiz de Montellano PR, (2008). 2.3Å X-ray structure of the heme-bound GAF domain of sensory histidine kinase DosT of Mycobacterium tuberculosis. Biochemistry 47: 12523-12531.
65. Poulos TL, (2006). Soluble guanylate cyclase. Curr Opin Struct Biol 16: 736-743.
66. Puranik M, Weeks CL, Lahaye D, Kabil Ö, Taoka S, Nielsen SB, et al. (2006). Dynamics of carbon monoxide binding to cystathionine β-synthease. J Biol Chem 281: 13433-13438.
67. Ragsdale SW, Yi L, Bender G, Gupta N, Kung Y, Yan L, et al. (2012). Redox, haem and CO in enzymatic catalysis and regulation. Biochem Soc Trans 40: 501-507.
68. Rahman MN, Vlahakis JZ, Szarek WA, Nakatsu K, Jin Z, (2008). X-ray crystal structure of human heme oxygenase-1 in complex with 1-(Adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors. J Med Chem 51: 5943-5952.
69. Rahman MN, Vlahakis JZ, Vukomanovic D, Szarek WA, Nakatsu K, Jia Z, (2009). X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-Chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode. J Med Chem 52: 4946-4950.
70. Rimmer RD, Pierri AE, Ford PC, (2012). Photochemically activated carbon monoxide release for biological targets. Toward developing air-stable photoCORMs labilized by visible light. Coord Chem Rev 256: 1509-1519.
71. Rochette L, Cottin Y, Zeller M, Vergely C, (2013). Carbon monoxide: mechanisms of action and potential clinical implications. Pharmacol Therap 137: 133-152.
72. Romanski S, Kraus B, Schatzschneider U, Neudörfl J, Amslinger S, Schmalz H-G, (2011). Acyloxybutadiene iron tricarbonyl complexes as enzyme-triggered CO-releasing molecules (ET-CORMs). Angew Chem Int Ed 50: 2392-2396.
73. Romanski S, Kraus B, Guttentag M, Schlundt W, Rücker H, Adler A, et al. (2012a). Acyloxybutadiene tricarbonyl iron complexes as enzyme-triggered CO-releasing molecules (ET-CORMs): a structure-activity relationship study. Dalton Trans 41: 13862-13875.
74. Romanski S, Rücker H, Stamellou E, Guttentag M, Neudörfl J, Alberto R, et al. (2012b). Iron dienylphosphate tricarbonyl complexes as water-soluble enzyme-triggered CO-releasing molecules (ET-CORMs). Organometallics 31: 5800-5809.
75. Romao CC, Blättler WA, Seixas JD, Bernardes GJL, (2012). Developing drug molecules for therapy with carbon monoxide. Chem Soc Rev 41: 3571-3583.
76. Ryter SW, Otterbein LE, Morse D, Choi AMK, (2002). Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234-235: 249-263.
77. Ryter SW, Alam J, Choi AMK, (2006). Heme oxygenase-1/carbon monoxide: from Basic science to therapeutic applications. Physiol Rev 86: 583-650.
78. 2(1,3-thiazole)], and the X-ray crystal structure of its adduct with lysozyme. J Inorg Biochem 117: 285-291.
79. Santos-Silva T, Mukhopadhyay A, Seixas JD, Bernardes GJL, Romao CC, Romao MJ, (2011). CORM-3 reactivity towards proteins: the crystal structure of a Ru(II) dicarbonyl-lysozyme complex. J Am Chem Soc 133: 1192-1195.
80. Schatzschneider U, (2010). Photoactivated biological activity of transition metal complexes. Eur J Inorg Chem: 1451-1467.
81. Schatzschneider U, (2011). PhotoCORMs: light-triggered release of carbon monoxide from the coordination sphere of transition metal complexes for biological applications. Inorg Chim Acta 374: 19-23.
82. Seixas JD, Mukhopadhyay A, Santos-Silva T, Otterbein LE, Gallo DJ, Rodrigues SS, et al. (2013). Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeutics. Dalton Trans 42: 5985-5998.
83. Süss-Fink G, (2010). Arene ruthenium complexes as anticancer agents. Dalton Trans 39: 1673-1688.
84. Szabo C, (2010). Gasotransmitters: new frontiers for translational science. Science Translat Med 2: 59ps54.
85. Szacilowski K, Macyk W, Drzewiecka-Matuszek A, Brindell M, Stochel G, (2005). Bioinorganic photochemistry: frontiers and mechanisms. Chem Rev 105: 2647-2694.
86. Tinberg CE, Tonzetich ZJ, Wang H, Do LH, Yoda Y, Cramer SP, et al. (2010). Characterization of iron dinitrosyl species formed in the reaction of nitric oxide with a biological Rieske center. J Am Chem Soc 132: 18168-18176.
87. Uchida T, Kitagawa T, (2005). Mechanism for transduction of the ligand-binding signal in heme-based gas sensory proteins revealed by resonance Raman spectroscopy. Acc Chem Res 38: 662-670.
88. Vreman HJ, Wong RJ, Kadotani T, Stevenson DK, (2005). Determination of carbon monoxide (CO) in rodent tissue: effect of heme administration and environmental CO exposure. Anal Biochem 341: 280-289.
89. Vreman HJ, Wong AP, Stevenson DK, (2011). Quantitating carbon monoxide production from heme by vascular plant preparations in vitro. Plant Physiol Biochem 49: 61-68.
90. Wang J, Karpus J, Zhao BS, Luo Z, Chen PR, He C, (2012). A selective fluorescent probe for carbon monoxide imaging in living cells. Angew Chem Int Ed 51: 9652-9656.
91. Ward JS, Lynam JM, Moir JWB, Sanin DE, Mountford AP, Fairlamb IJS, (2012). A therapeutically viable photo-activated manganese-based CO-releasing molecule (photo-CO-RM). Dalton Trans 41: 10514-10517.
92. Weeks CL, Singh S, Madzelan P, Banerjee R, Sprio TG, (2009). Heme regulation of human cystathionine β-synthase activity: insights from fluorescence and Raman spectroscopy. J Am Chem Soc 131: 12809-12816.
93. Wegiel B, Hanto DW, Otterbein LE, (2013). The social network of carbon monoxide in medicine. Trends Mol Med 19: 3-11.
94. Wilkinson WJ, Kemp PJ, (2011). Carbon monoxide: an emerging regulator of ion channels. J Physiol 589: 3055-3062.
95. Wu L, Wang R, (2005). Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57: 585-630.
96. Yuan L, Lin W, Tan L, Zheng K, Huang W, (2013). Lighting up carbon monoxide: fluorescent probes for monitoring CO in living cells. Angew Chem Int Ed 52: 1628-1630.
97. Zobi F, (2013). Carbon monoxide and CO-releasing molecules in medicinal chemistry. Future Med Chem 5: 175-188.
98. - rhenium dicarbonyl CO-releasing molecules on a cobalamin scaffold for biological application. Dalton Trans 41: 370-378.